Psychemedics

Psychemedics Assets per Share

The Total Assets per Share of Psychemedics (PMDI) as of Oct 17, 2026 is 1.36 USD. In the previous year, Total Assets per Share was 2.02 USD — a change of -32.52% (lower).

Assets per Share

1.36USD

YoY

-32.52%

Last updated:

Total Assets per Share of Psychemedics is 2024 1.36 USD. Total Assets per Share of Psychemedics was 2023 2.02 USD. It decreases by -32.52% lower compared to the previous year.

The Psychemedics Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2017
4.34 USD
Jan 1, 2018
4.09 USD
Jan 1, 2019
4.51 USD
Jan 1, 2020
3.93 USD
Jan 1, 2021
3.53 USD
Jan 1, 2022
3.07 USD
Jan 1, 2023
2.02 USD
Jan 1, 2024
1.36 USD
The Psychemedics Assets per Share history
YEARAssets per ShareYoY
1.36USD-32.52%
2.02USD-34.20%
3.07USD-13.08%
3.53USD-10.21%
3.93USD-12.81%
4.51USD+10.25%
4.09USD-5.81%
4.34USD+5.91%
4.10USD+13.57%
3.61USD-8.47%
3.94USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp, trading under the ticker PMDI, is a U.S.-based company headquartered in Acton, Massachusetts. The company specializes in drug testing services, focusing on the analysis of hair samples to detect the presence of drugs of abuse. With 204 full-time employees, Psychemedics operates within the Health Care sector, specifically in the Health Care industry. The company's primary service involves conducting drug tests and reporting results to clients, including training for sample collection and storage of positive samples for a fee per unit tested. Its testing methodology provides detailed information on the approximate amount of drug ingested and historical data on drug use patterns over time. Psychemedics went public on January 22, 1987, marking the beginning of its journey as a publicly traded entity. The company's website, https://www.psychemedics.com/, serves as a primary source of information for its services and operations. While the company's core business is centered on drug testing, it does not disclose specific product names or additional services beyond the scope of hair sample analysis and reporting. Psychemedics maintains a presence in the U.S. market, with its operations primarily focused on providing reliable and detailed drug testing solutions to its clients. The company's approach to testing emphasizes both the immediate detection of drug use and the ability to track usage patterns over extended periods, offering a comprehensive service for its customers. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

Total Assets per Share of Psychemedics is 1.36 USD in 2024.

Total Assets per Share of Psychemedics changed from 2.02 USD to 1.36 USD, representing a -32.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Psychemedics since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Psychemedics

All Key Metrics — Psychemedics